PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM
In a surgeon’s practice, complicated intra-abdominal infections (CII) are one of the most frequent nosological entities. E. Proteus spp., Klebsiella spp. are considered to be leading activators of out-of-hospital CII. For the first time in a Russian economic environment the authors, using mathematic...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2010-02-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/1194 |
id |
doaj-b9cc1f1a9ac54982902aaa920c92a866 |
---|---|
record_format |
Article |
spelling |
doaj-b9cc1f1a9ac54982902aaa920c92a8662020-11-24T22:01:38ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892010-02-017129401189PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEMA.S. Kolbin0Yu.B. Belousov1S.V. Sidorenko2K.A. Goryachkina3O.A. Koroleva4D.Yu. Belousov5N.N. Klimko6Medical Faculty of the Saint-Petersburg UniversityRussian State Medical University, MoscowScientific-Research Institute of Infection diseases, Saint-PetersburgI.I. Mechnikov’s Saint-Petersburg State Medical AcademyApplied Mathematics and Management Process Faculty — Saint-Petersburg State UniversityООО Centre for Pharmacoeconomic Research, MoscowSaint-Petersburg Medical Post-Graduate AcademyIn a surgeon’s practice, complicated intra-abdominal infections (CII) are one of the most frequent nosological entities. E. Proteus spp., Klebsiella spp. are considered to be leading activators of out-of-hospital CII. For the first time in a Russian economic environment the authors, using mathematical modeling methods, have conducted a clinical and economic research of the new carbapenem, ertapenem, for monotherapy of complicated intra-abdominal infections. They have calculated the total cost, including the cost of CII treatment subject to indicators such as efficiency of treatment and infection-related probability of death (attributive lethality). Results of the «susceptible-infected-susceptible» model were used to assess the impact of acquired bacterial resistance on the efficacy of treating complicated intra-abdominal infections. As a result it was found that in the case of out-of-hospital complicated intraabdominal infections, it is more advisable from the clinical and economic standpoint to start treatment with ertapenem; less advisable is to start with the combination of ceftriaxone and metronidazole or the combination of ciprofloxacin and metronidazole. Key words: clinical and economic analysis, ertapenem, complicated intra-abdominal infections, resistance. (Pediatric Pharmacology. – 2010; 7(1):29-40)https://pf.spr-journal.ru/jour/article/view/1194 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A.S. Kolbin Yu.B. Belousov S.V. Sidorenko K.A. Goryachkina O.A. Koroleva D.Yu. Belousov N.N. Klimko |
spellingShingle |
A.S. Kolbin Yu.B. Belousov S.V. Sidorenko K.A. Goryachkina O.A. Koroleva D.Yu. Belousov N.N. Klimko PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM Pediatričeskaâ Farmakologiâ |
author_facet |
A.S. Kolbin Yu.B. Belousov S.V. Sidorenko K.A. Goryachkina O.A. Koroleva D.Yu. Belousov N.N. Klimko |
author_sort |
A.S. Kolbin |
title |
PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM |
title_short |
PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM |
title_full |
PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM |
title_fullStr |
PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM |
title_full_unstemmed |
PHARMACOECONOMIC ANALYSIS OF TREATMENT OF OUT-OF-HOSPITAL COMPLICATED ABDOMINAL INFECTIONS WITH NEW-GENERATION CARBAPENEM — ERTAPENEM |
title_sort |
pharmacoeconomic analysis of treatment of out-of-hospital complicated abdominal infections with new-generation carbapenem — ertapenem |
publisher |
Paediatrician Publishers, LLC |
series |
Pediatričeskaâ Farmakologiâ |
issn |
1727-5776 2500-3089 |
publishDate |
2010-02-01 |
description |
In a surgeon’s practice, complicated intra-abdominal infections (CII) are one of the most frequent nosological entities. E. Proteus spp., Klebsiella spp. are considered to be leading activators of out-of-hospital CII. For the first time in a Russian economic environment the authors, using mathematical modeling methods, have conducted a clinical and economic research of the new carbapenem, ertapenem, for monotherapy of complicated intra-abdominal infections. They have calculated the total cost, including the cost of CII treatment subject to indicators such as efficiency of treatment and infection-related probability of death (attributive lethality). Results of the «susceptible-infected-susceptible» model were used to assess the impact of acquired bacterial resistance on the efficacy of treating complicated intra-abdominal infections. As a result it was found that in the case of out-of-hospital complicated intraabdominal infections, it is more advisable from the clinical and economic standpoint to start treatment with ertapenem; less advisable is to start with the combination of ceftriaxone and metronidazole or the combination of ciprofloxacin and metronidazole. Key words: clinical and economic analysis, ertapenem, complicated intra-abdominal infections, resistance. (Pediatric Pharmacology. – 2010; 7(1):29-40) |
url |
https://pf.spr-journal.ru/jour/article/view/1194 |
work_keys_str_mv |
AT askolbin pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT yubbelousov pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT svsidorenko pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT kagoryachkina pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT oakoroleva pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT dyubelousov pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem AT nnklimko pharmacoeconomicanalysisoftreatmentofoutofhospitalcomplicatedabdominalinfectionswithnewgenerationcarbapenemertapenem |
_version_ |
1725839281842290688 |